BioHarvest BHST Slips 247 Testing 393 Support 20260515 US Economic Growth Rebounds 2 as Consumer Spending Cools Amid Geopolitical Tensions LouisianaPacific Corporation LPX Slips 339 Testing 6466 Support 20260519 Ispire Technology ISPR Q1 2026 Earnings Miss by Significant Key Takeaways Trump Investment Fuels Kura Sushis Ambitions in the US Market Pioneer PACHW Gains 095 Support Holds at 020 20260520 ATTs BlueCollar Talent Hunt Signals Shift in AIDriven Economy Merchants Bancorp MBIN Stock Today Rallies 119 Resistance at 4746 20260520 Judge Dismisses Charges Against Mistakenly Deported Man Exposing Legal and Financial Risks in Immigration Enforcement Chinas DeepSeek AI Claims Breakthrough HighPerformance Models Trained Without Advanced Chips Airtel Defends Priority Postpaid Plan Before DoT Panel Cites Regulatory Framework for Network Slicing Gokaldas Exports Reports 9 Sequential Revenue Growth in Q4 Driven by Productivity Gains and Cost Controls Prediction Market Investment Surge Continues Despite Regulatory Uncertainty Earnings Calls Reveal Firm Commitment Trump Asks Supreme Court to Halt TikTok Ban Adding Uncertainty to Platforms Future NCMI Q1 2026 Earnings EPS Miss Exceeds Estimates Stock Edges Higher SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds LH Q1 2026 Earnings Labcorp Beats EPS Estimates but Stock Slips Slightly TBH Q4 2025 Earnings Massive EPS Miss Highlights Operational Challenges PUK Q4 2025 Earnings EPS Misses Estimates by 2917 Stock Declines Standard Chartered Announces Significant Job Cuts in Corporate Functions to Boost Efficiency Ballard Power Systems BLDP Q1 2026 Earnings Narrowed Loss Exceeds Expectations RVSN Q3 2023 Earnings EPS Exceeds Estimates Despite Absence of Revenue PTEN Q1 2026 Earnings EPS Surprises Positive NarrowerThanExpected Loss HLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds ThredUp Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares SFNC Q1 2026 Earnings Slight EPS Miss Amid Stable Operations CBOE Q1 2026 Earnings EPS Surges Past Estimates on Strong Trading Activity Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management